3.1584
Impact BioMedical, Inc. Azioni (IBO) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
57.14%
0.003
|
0.007 | 0.007 | 0.018 | 0.007 |
| Cost Of Revenue |
0.001
|
- | 0.422 | 0.001 | 0.011 |
|
|
89.69%
0.167
|
1.62 | 0.118 | 0.261 | 0.246 |
| Depreciation and Amortization |
0.35%
0.284
|
0.285 | 0.286 | 0.288 | 0.288 |
| Operating Income/Loss |
69.33%
-0.702
|
-2.289 | -1.17 | -0.948 | -1.153 |
| Income/Loss From Continuing Operations Before Tax |
69.35%
-0.70
|
-2.284 | 2.655 | -1.475 | -14.35 |
| Net Income/Loss |
69.35%
-0.70
|
-2.284 | 5.235 | -1.475 | -14.35 |
| Attributable To Noncontrolling Interest |
133.33%
-0.001
|
0.003 | -0.01 | -0.005 | -0.006 |
| Basic Average Shares |
0.03%
107.82
|
107.79 | - | 12.19 | 12.19 |
| Basic Earnings Per Share |
50.00%
-0.01
|
-0.02 | - | -0.12 | -1.18 |
| Diluted Earnings Per Share |
50.00%
-0.01
|
-0.02 | - | -0.12 | -1.18 |
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):